You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antitumor Immunity

Showing 1 - 25 of 2,923
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Unresectable Head and Neck

Terminated
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • +2 more
  • ImmunoPulse
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Sep 1, 2022

Melanoma Trial in Milan (AEP Group Walking Sessions, CEP Group Walking Sessions)

Recruiting
  • Melanoma
  • AEP Group Walking Sessions
  • CEP Group Walking Sessions
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Nov 8, 2022

Small Cell Lung Carcinoma Trial in Milano (Cyclic, 5-day calorie restriction, Atezolizumab)

Not yet recruiting
  • Small Cell Lung Carcinoma
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Jan 19, 2023

Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant

Completed
  • Solid Tumor
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
  • (no location specified)
Jun 8, 2023

MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC

Not yet recruiting
  • Lung Neoplasms
  • +2 more
  • Tumor samples
  • Bordeaux, France
    CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
Aug 28, 2023

Advanced Breast Cancer, Objective Response Rate, Trastuzumab Emtansine Trial in Nanjing (Trastuzumab Emtansine (T-DM1))

Recruiting
  • Advanced Breast Cancer
  • +2 more
  • Trastuzumab Emtansine (T-DM1)
  • Nanjing, Jiangsu, China
    JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Nov 5, 2023

Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays

Not yet recruiting
  • Lung Neoplasm
  • +2 more
  • Tumor samples
  • Bordeaux, France
    CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
Aug 28, 2023

Upper Aerodigestive Malignancies

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Collection of biological specimens
  • Baltimore, Maryland
    Johns Hopkins University
Aug 9, 2023

Solid Tumor, Adult Trial in Spain, United States (RBN-2397)

Recruiting
  • Solid Tumor, Adult
  • Aurora, Colorado
  • +14 more
Jul 5, 2022

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Melanoma Trial in Darmstadt, MIlan, Pavia (Carbon Ion

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Carbon Ion Therapy
  • Immunotherapy (Pembrolizumab)
  • Darmstadt, Germany
  • +3 more
Feb 11, 2022

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Advanced Solid Tumor Trial in United States (Part 1 ES002023, Part 2 ES002023)

Active, not recruiting
  • Advanced Solid Tumor
  • Part 1 ES002023
  • Part 2 ES002023
  • Scottsdale, Arizona
  • +6 more
Oct 18, 2022

Advanced Squamous Non-Small Cell Lung Carcinoma Trial in Worldwide (RBN-2397)

Recruiting
  • Advanced Squamous Non-Small Cell Lung Carcinoma
  • Newark, Delaware
  • +18 more
Jan 19, 2023

Extranodal NK/T-cell Lymphoma Trial in Korea, Republic of (VT-EBV-N, Placebo)

Recruiting
  • Extranodal NK/T-cell Lymphoma
  • VT-EBV-N
  • Placebo
  • Busan, Korea, Republic of
  • +7 more
Apr 28, 2022

Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

Recruiting
  • Solid Tumor, Adult
  • +5 more
  • Seongnam, Korea, Republic of
  • +2 more
Oct 11, 2023

Advanced Lung Non-Small Cell Carcinoma, Non-Small Cell Carcinoma of Lung, TNM Stage 4 Trial in Boston (Granulocyte-Macrophage

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • Non-Small Cell Carcinoma of Lung, TNM Stage 4
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • +4 more
  • Boston, Massachusetts
    Tufts Medical Center
Oct 3, 2022

Solid Tumor, Carcinoma, Malignancy Trial in Hong Kong (propofol, sevoflurane)

Recruiting
  • Solid Tumor
  • +3 more
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Mar 14, 2022

MSI-H Colorectal Cancer Trial in Pittsburgh (Regorafenib, Pembrolizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 17, 2023

Metastatic Cervical Cancer Trial (Tislelizumab, Sitravatinib)

Not yet recruiting
  • Metastatic Cervical Cancer
  • (no location specified)
Jan 31, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma Trial in Rochester (Anti-PD-L1 Monoclonal Antibody

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Anti-PD-L1 Monoclonal Antibody IMC-001
  • Punch Biopsy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Colorectal Cancer, Colorectal Tumors Malignant, Intestinal Tumors, Malignant Trial in Shanghai (Ileostomy, Transverse colostomy)

Recruiting
  • Colorectal Cancer
  • +2 more
  • Ileostomy
  • Transverse colostomy
  • Shanghai, China
    Fudan University Shanghai Cancer Center
May 2, 2023

Lung Cancer, Nonsmall Cell Trial in Sacramento ([18F]F-AraG Imaging)

Enrolling by invitation
  • Lung Cancer, Nonsmall Cell
  • [18F]F-AraG Imaging
  • Sacramento, California
    UC Davis EXPLORER Molecular Imaging Center
Jan 4, 2023

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Tucson (Tadalafil 20 MG)

Not yet recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Tadalafil 20 MG
  • Tucson, Arizona
    Arizona Cancer Center at UMC North/University Medical Center
Feb 1, 2023

Gynecological Cancer Patients Receiving Immunotherapy

Recruiting
  • Gynecologic Cancer
  • +2 more
    • Orlando, Florida
      AdventHealth Cancer Institute
    Oct 13, 2021

    Breast Cancer, Triple Negative Breast Cancer, Dietary Exposure Trial (Control diet (ARM A) or Fasting-Like Approach (FLA, ARM

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Control diet (ARM A) or Fasting-Like Approach (FLA, ARM B)
    • (no location specified)
    Feb 28, 2023